why choose us

First received: January 25, 2023

Clinical Trial: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Prurigo

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis

Brief Summary: The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).

Read more